Vermont becomes first state to allow wholesale importation of prescription drugs
Gov. Phil Scott (R) signed S 175. The legislation was unanimously approved in the Senate on March 1 and passed in the House by a 141-2 vote on May 2. The Senate unanimously concurred with House amendments on May 7.
S 175 directs the state Agency of Human Services to design a program to import wholesale prescription drugs from Canada. Drugs included in the program would have to meet U.S. Food and Drug Administration (FDA) standards and "generate substantial savings for Vermont consumers."
The agency must submit a program proposal to the legislature by January 1, 2019, and a formal request to the U.S. Department of Health and Human Services by July 1, 2019. The bill limited the agency from implementing the program until the General Assembly enacted legislation establishing a charge per prescription.
It is unclear whether the federal government would approve the plan. Health and Human Services Secretary Alex Azar said he did not think the idea would work. Azar said Canada didn't have enough drugs to sell to the U.S. for less money and added that the FDA was concerned there would be no way to verify that drugs were from Canada and not "routed from a counterfeit factory in China."
Bill co-sponsor Sen. Virginia Lyons (D) said, "We've found that drugs from Canada are very safe and the equivalent of FDA-approved, and we could keep our costs down by having our own wholesale importer and allow our people to buy at this reduced cost. It's about time that happened."
|